Philippe Couttet

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Transcriptional changes in non-human primate tissues after intrathecal delivery of serotype 9 adeno-associated viral vector: Insights into organ toxicities.

Transcriptional changes in non-human primate tissues after intrathecal delivery of serotype 9 adeno-associated viral vector: Insights into organ toxicities.

Journal: Molecular therapy. Methods & clinical development

Published: May 29, 2025

Liver enzyme delayed clearance in rat treated by CSF1 receptor specific antagonist Sotuletinib.

Liver enzyme delayed clearance in rat treated by CSF1 receptor specific antagonist Sotuletinib.

Journal: Current research in toxicology

Published: July 12, 2022

Identification of marker genes to monitor residual iPSCs in iPSC-derived products.

Identification of marker genes to monitor residual iPSCs in iPSC-derived products.

Journal: Cytotherapy

Published: March 18, 2022

Methodological considerations for measuring biofluid-based microRNA biomarkers.

Methodological considerations for measuring biofluid-based microRNA biomarkers.

Journal: Critical reviews in toxicology

Published: May 26, 2021

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4.

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4.

Journal: Journal of medicinal chemistry

Published: September 15, 2020

Transcriptomic Analysis of Cholestatic Compounds In Vitro.

Transcriptomic Analysis of Cholestatic Compounds In Vitro.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 25, 2019

Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.

Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.

Journal: Frontiers in immunology

Published: February 07, 2019

FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.

FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.

Journal: Molecular cancer therapeutics

Published: December 16, 2018

Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes.

Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes.

Journal: The Journal of pharmacology and experimental therapeutics

Published: October 16, 2018

Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.

Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: February 13, 2018

Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo.

Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo.

Journal: Journal of medicinal chemistry

Published: January 24, 2018

Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR.

Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR.

Journal: BMC biotechnology

Published: May 31, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026